Orphan Designation Criteria under EMA: A Regulatory Guide for Rare Disease Drug Development
Orphan Designation Criteria under EMA: A Regulatory Guide for Rare Disease Drug Development Understanding EMA’s Orphan Designation Criteria for Rare Disease Medicines The European Medicines Agency (EMA) plays a vital role in facilitating drug development for rare diseases through its orphan medicinal product (OMP) designation program. This special regulatory status offers numerous incentives to pharmaceutical…